CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net earnings	$ 6,681,000	$ 8,277,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	1,025,000	1,018,000
Amortization	177,000	194,000
Deferred taxes	0	(1,157,000)
Premium amortization, net of discount accretion	435,000	760,000
Net realized gain on sales of securities available for sale	0	(93,000)
Gain on sale of loans	(272,000)	(314,000)
Reversal of provision for credit losses	(250,000)	0
Origination of loans held for sale	(7,798,000)	(10,488,000)
Proceeds from loans held for sale	8,172,000	12,698,000
Net gain on sale of premises, equipment, other real estate owned and other assets	(11,000)	0
Stock based compensation	138,000	148,000
Net change in accrued interest receivable and other assets	(8,627,000)	(930,000)
Net change in accrued interest payable and other liabilities	1,450,000	1,599,000
Net cash provided by operating activities	1,120,000	11,712,000
Securities available for sale:
Purchases	(439,214,000)	0
Proceeds from Sales	0	7,239,000
Proceeds from maturities and principal repayments	404,493,000	7,396,000
Securities held to maturity:
Proceeds from maturities and principal repayments	39,806,000	32,305,000
Net repayments of loans	42,173,000	5,000
Purchases of premises and equipment	(997,000)	(2,184,000)
Proceeds from sale of premises, equipment, other real estate owned and other assets	124,000	0
Net cash provided by investing activities	46,385,000	44,761,000
Cash flows from financing activities
Net change in deposits	(5,402,000)	(57,786,000)
Net change in securities sold under agreements to repurchase	13,886,000	6,117,000
Proceeds from FHLB advances	590,000,000	1,585,000,000
Repayment of FHLB advances	(655,000,000)	(1,535,000,000)
Repayment of line of credit	(4,500,000)	0
Purchase of treasury stock	(335,000)	(744,000)
Exercise of stock options	69,000	225,000
Cash dividends paid	(2,654,000)	(2,627,000)
Net cash used in financing activities	(63,936,000)	(4,815,000)
Net change in cash and cash equivalents	(16,431,000)	51,658,000
Cash and cash equivalents at beginning of period	89,524,000	106,467,000
Cash and cash equivalents at end of period	73,093,000	158,125,000
Supplemental disclosures of cash flow information
Interest paid	16,849,000	10,467,000
Supplemental schedule of noncash investing and financing activities
Cash dividends accrued	2,769,000	2,744,000
Lease right of use assets obtained in exchange for lease liabilities	0	568,000
Transfer of loans to other real estate owned and repossessed assets	$ 14,946,000	$ 0